Holen Sie sich die Stockscreener-App
1.09
3.81%
0.04
Schlusskurs vom Vortag:
$1.05
Offen:
$1.09
24-Stunden-Volumen:
668.69K
Relative Volume:
0.47
Marktkapitalisierung:
$89.75M
Einnahmen:
$65,300
Nettoeinkommen (Verlust:
$-84.95M
KGV:
-0.5638
EPS:
-1.9332
Netto-Cashflow:
$-88.92M
1W Leistung:
-37.36%
1M Leistung:
-37.36%
6M Leistung:
-57.42%
1J Leistung:
-25.34%
1-Tages-Spanne:
$1.07
$1.11
1-Wochen-Bereich:
$1.05
$1.36
52-Wochen-Spanne:
$1.05
$2.9789
Inovio Pharmaceuticals Inc Stock (INO) Company Profile
Firmenname
Inovio Pharmaceuticals Inc
Sektor
Branche
Telefon
(858) 410-3134
Adresse
660 W. GERMANTOWN PIKE, PLYMOUTH MEETING, PA
Compare INO vs VRTX, REGN, ARGX, ALNY, INSM
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
INO
Inovio Pharmaceuticals Inc
|
1.10 | 85.67M | 65,300 | -84.95M | -88.92M | -1.9332 |
VRTX
Vertex Pharmaceuticals Inc
|
438.65 | 109.85B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
766.61 | 80.38B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
779.72 | 47.60B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
327.39 | 42.63B | 3.71B | 313.75M | 465.38M | 2.2571 |
INSM
Insmed Inc
|
157.25 | 35.19B | 606.42M | -1.28B | -997.58M | -6.403 |
Inovio Pharmaceuticals Inc Stock (INO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-09 | Eingeleitet | Piper Sandler | Overweight |
| 2024-05-14 | Eingeleitet | Stephens | Overweight |
| 2024-01-25 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2022-11-09 | Herabstufung | Maxim Group | Buy → Hold |
| 2022-11-01 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2022-07-19 | Fortgesetzt | RBC Capital Mkts | Sector Perform |
| 2022-05-11 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2022-01-21 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2021-12-29 | Fortgesetzt | Jefferies | Hold |
| 2021-09-10 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2021-06-24 | Eingeleitet | Jefferies | Hold |
| 2021-03-23 | Eingeleitet | BofA Securities | Neutral |
| 2021-02-12 | Eingeleitet | Oppenheimer | Outperform |
| 2020-11-17 | Herabstufung | ROTH Capital | Neutral → Sell |
| 2020-11-10 | Hochstufung | ROTH Capital | Sell → Neutral |
| 2020-09-28 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2020-09-28 | Hochstufung | Maxim Group | Hold → Buy |
| 2020-07-01 | Herabstufung | Maxim Group | Buy → Hold |
| 2020-07-01 | Herabstufung | ROTH Capital | Neutral → Sell |
| 2020-06-29 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2020-06-26 | Herabstufung | Stifel | Buy → Hold |
| 2020-05-21 | Eingeleitet | The Benchmark Company | Buy |
| 2020-04-30 | Herabstufung | ROTH Capital | Buy → Neutral |
| 2020-03-13 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2020-03-13 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2019-12-19 | Eingeleitet | ROTH Capital | Buy |
| 2018-02-15 | Bestätigt | Maxim Group | Buy |
| 2017-10-18 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2017-09-06 | Eingeleitet | Citigroup | Buy |
| 2017-06-08 | Hochstufung | Piper Jaffray | Neutral → Overweight |
| 2017-05-24 | Bestätigt | Maxim Group | Buy |
| 2017-03-16 | Hochstufung | Maxim Group | Hold → Buy |
| 2017-03-16 | Herabstufung | Piper Jaffray | Overweight → Neutral |
Alle ansehen
Inovio Pharmaceuticals Inc Aktie (INO) Neueste Nachrichten
What's Going On With Inovio Pharmaceuticals Stock On Tuesday? - Sahm
Inovio Pharmaceuticals, Inc. (NASDAQ: INO) Investor Alert: Deadline in Lawsuit on April 07, 2026 - openPR.com
INO Shareholder Alert: April 7, 2026 Lead Plaintiff Deadline in Inovio Pharmaceuticals, Inc. Securities Class Action Lawsuit -- The Gross Law Firm - PR Newswire
Inovio Pharmaceuticals Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Inovio (NASDAQ: INO) sets 2026 vote and outlines INO-3107 FDA path - Stock Titan
Pomerantz Law Firm Announces the Filing of a Class Action Against Inovio Pharmaceuticals, Inc. and Certain Officers – INO - GlobeNewswire Inc.
INO Deadline Today: INO Investors with Losses in Excess of $100K Have Opportunity to Lead Inovio Pharmaceuticals, Inc. Securities Fraud Lawsuit - Morningstar
Inovio Deadline Today: Rosen Law Firm Urges Inovio Pharmaceuticals, Inc. (NASDAQ: INO) Stockholders - PharmiWeb.com
Inovio Deadline Today: Rosen Law Firm Urges Inovio Pharmaceuticals, Inc. (NASDAQ: INO) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their Rights - The Joplin Globe
INO CLASS ACTION DEADLINE TONIGHT: Faruqi & Faruqi, LLP Reminds Inovio Pharmaceuticals Investors of Securities Class Action Deadline on April 7, 2026 - Eagle-Tribune
INO Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Inovio Pharmaceuticals, Inc. Securities Lawsuit -- The Gross Law Firm - PR Newswire
Pre-market top loser: GBM.F Inovio Pharmaceuticals (XETRA) -34.80% 07 Apr 2026: catalyst timeline key - Meyka
Inovio Faces Class Action Lawsuit Over Regulatory Disclosures - National Today
Bragar Eagel & Squire, P.C. Urgently Reminds Investors that - GlobeNewswire
Inovio prices $17.5 million public offering of shares and warrants - MSN
Levi & Korsinsky Announces the Filing of a Securities Class - GlobeNewswire
Bronstein, Gewirtz & Grossman LLC Urges Inovio - GlobeNewswire
Portnoy Law Firm Announces Class Action on Behalf of Inovio Pharmaceuticals, Inc. Investors - WFXG
DEADLINE ALERT for TCPC, ORCL, PSFE, and INO: The Law - GlobeNewswire
Inovio: 'Hold' As Upcoming PDUFA For INO-3107 Is Major Inflection Point (NASDAQ:INO) - Seeking Alpha
Inovio Pharmaceuticals Announces New Public Equity Offering - TipRanks
INO Stockholders Have Opportunity to Lead Inovio Pharmaceuticals, Inc. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today! - accessnewswire.com
Inovio Pharmaceuticals Launches $16 Million Stock-and-Warrant Offering Underwritten by Piper Sandler - TradingView
Inovio (Nasdaq: INO) prices $17.5M stock and dual-warrant public offering - Stock Titan
INO Investors Have Opportunity to Lead Inovio Pharmaceuticals, Inc. Securities Fraud Lawsuit with the Schall Law Firm - PR Newswire
INO FINAL DEADLINE: ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Inovio Pharmaceuticals Inc. ... - Caledonian Record
UNIQURE DEADLINE: ROSEN, A LEADING AND LONGSTANDING FIRM, Encourages uniQure N.V. Investors with Losses in Excess of $100K to Secure Counsel Before Important April 13 Deadline in Securities Class Action - GlobeNewswire Inc.
Inovio Pharmaceuticals Faces Stock Dilution and Legal Battles - timothysykes.com
Stock Report: Is Inovio Pharmaceuticals Inc a potential multi baggerQuarterly Earnings Summary & Consistent Profit Trading Strategies - baoquankhu1.vn
Inovio Pharmaceuticals, Inc. (INO) stock price, news, quote and history - Yahoo Finance UK
INO SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Reminds Inovio Pharmaceuticals (INO) Investors of Securities Class Action Deadline on April 7, 2026 - PR Newswire
INO Deadline: INO Investors with Losses in Excess of $100K Have Opportunity to Lead Inovio Pharmaceuticals, Inc. Securities Fraud Lawsuit - Sahm
INO Shareholders Have Opportunity to Lead Inovio Pharmaceuticals, Inc. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today! - ACCESS Newswire
Inovio Pharmaceuticals, Inc. (INO) Stock Price, News, Quote & History - Yahoo! Finance Canada
Deadline Alert: Inovio Pharmaceuticals, Inc. (INO) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit - globenewswire.com
Inovio (INO) Loses 32.7% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner - Yahoo Finance
Inovio Pharmaceuticals proposes securities offering - MSN
Inovio prices $17.5M stock offering with warrants By Investing.com - Investing.com Canada
What's Behind The Drop In Inovio Pharmaceuticals Stock Today? - Sahm
INO Deadline: INO Investors with Losses in Excess of $100K Have - GuruFocus
Inovio Pharmaceuticals Inc. stock underperforms Thursday when compared to competitors - MarketWatch
12.5M‑share unit offering with warrants, INOVIO (NASDAQ: INO) — $1.40/unit - Stock Titan
ROSEN, THE FIRST FILING FIRM, Encourages Trip.com Group Limited Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - GlobeNewswire Inc.
What's behind the drop in Inovio Pharmaceuticals stock today? - MSN
Inovio Pharmaceuticals stock tumbles on dilutive offering By Investing.com - Investing.com Canada
Inovio Pharmaceuticals stock tumbles on dilutive offering - Investing.com
Inovio Pharmaceuticals suspends at-the-market offering prospectus By Investing.com - Investing.com Canada
Inovio Plummets 34.5%: Biotech's Volatile Move Sparks Market Alert - Bitget
INO SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Reminds Inovio Pharmaceuticals (INO) ... - Bluefield Daily Telegraph
INOVIO Pharmaceuticals Announces Public Offering of Common Stock - Intellectia AI
Finanzdaten der Inovio Pharmaceuticals Inc-Aktie (INO)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.21%
2.58%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):